The webinar will feature presentations by Dr. Pippa Curtis-Jackson, Senior Specialist at the Chemical Assessment Unit, UK EA, and Dr. Michelle Embry, Deputy Director of HESI.
Similar Posts
Guidance Documents for Drug Applications
Guidance documents are prepared for FDA review staff and applicants/sponsors to provide guidelines to the processing, content, and evaluation/approval of applications and also to the design, production, manufacturing, and testing of regulated products.CANCELED – 17th Annual Sentinel Initiative Public Workshop – 11/06/2025
The U.S. Food and Drug Administration, under a cooperative agreement with the Duke-Margolis Institute for Health Policy, is hosting the 16th Annual Sentinel Initiative Public Workshop on November 6, 2025National Drug Code Database Background Information
National Drug Code Database Background InformationMatrixx Initiatives Inc. (Zicam), Scottsdale, AZ 483 issued 5/28/2009 (1 page)
Matrixx Initiatives Inc. (Zicam), Scottsdale, AZ 483 issued 5/28/2009 (1 page)E2D(R1) Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports
E2D(R1) Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety ReportsBiosimilars | Science and Research
Learn about FDA’s latest in biosimilar science and research.